As for ERAP2, a multidisciplinary integrated analysis revealed its overexpression, along with other candidate genes, in papillary thyroid carcinoma (PTC) and the cystic fluid counterpart, pointing out a possible translocation from the canonical ER localization (18). This evidence concerns the gene ERAP2 and thyroid gland papillary carcinoma.